Really exciting: Motif Neurotech just got FDA clearance to trial its DOT implant for treatment-resistant depression, and the key detail is where it sits: on top of the skull, not inside the brain. That alone could change the calculus for patients who need neurostimulation but

→ View original post on X — @kimmonismus,